Suppliers / Wealphar Pharmaceutical Joint Stock

Wealphar Pharmaceutical Joint Stock

Updated 9 July 2026

Wealphar Pharmaceutical Joint Stock is an API and finished-dose manufacturer. It appears in 294 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
294
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Ramipril DAV (Vietnam) 3
Valsartan DAV (Vietnam) 3
Carbocisteine DAV (Vietnam) 2
Etodolac DAV (Vietnam) 2
Haloperidol DAV (Vietnam) 2
Ketoprofen DAV (Vietnam) 2
L-Ornithin L-Aspartat DAV (Vietnam) 2
Metronidazole DAV (Vietnam) 2
Naproxen DAV (Vietnam) 2
Pravastatin DAV (Vietnam) 2
Show all 30 molecules on file
Rosuvastatin DAV (Vietnam) 2
Acetylsalicylic Acid DAV (Vietnam) 1
Bisoprolol DAV (Vietnam) 1
Captopril DAV (Vietnam) 1
Cetirizine DAV (Vietnam) 1
Cimetidine DAV (Vietnam) 1
Dexibuprofen DAV (Vietnam) 1
Dexlansoprazole DAV (Vietnam) 1
Donepezil DAV (Vietnam) 1
Doxazosin DAV (Vietnam) 1
Ebastine DAV (Vietnam) 1
Ferrous DAV (Vietnam) 1
Fexofenadine DAV (Vietnam) 1
Fluvoxamine DAV (Vietnam) 1
Hydroclorothiazide DAV (Vietnam) 1
Ibuprofen DAV (Vietnam) 1
Irbesartan DAV (Vietnam) 1
Isoleucine DAV (Vietnam) 1
Lovastatin DAV (Vietnam) 1
Mequitazine DAV (Vietnam) 1

Also appears on these molecule pages

Show 6 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 294 None

Comparing suppliers?

Choose your molecules and target markets. Wealphar Pharmaceutical Joint Stock comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability